Hepatitis B virus infection among refugees resettled in the U.S.: High prevalence and challenges in access to health care

Journal of Immigrant and Minority Health

Volumn 12, Issue 6, 2010, Pages 823-827

  Museru, Oidda Ikumboka ^a   Vargas, Monica ^b   Kinyua, Mary ^a   Alexander, Kelly T ^a   Franco Paredes, Carlos ^a,d   Oladele, Alawode ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA DEPARTMENT OF HUMAN RESOURCES   (United States)

^c Refugee Health Program   (United States)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Chronic hepatitis B; Cirrhosis; Hepatitis B; Hepatocellular carcinoma; Refugees

Indexed keywords

ADOLESCENT; ADULT; AFRICA; ARTICLE; CHILD; ETHNOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; REFUGEE; RETROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADULT; AFRICA; CHILD; FEMALE; GEORGIA; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; REFUGEES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78649634168     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-010-9335-7     Document Type: Article

References (22)

1. R Gish M Giodavi 2006 Chronic hepatitis B: current epidemiology in the Americas and implication for management J Viral Hepatitis 13 787 798 1:STN:280:DC%2BD28nntlWgtg%3D%3D 10.1111/j.1365-2893.2006.00787.x (Pubitemid 44748283)
2. D Lavanchy 2004 Hepatitis B virus epidemiology, disease burden, treatment, and current emerging prevention and control measure J Viral Hepatitis 11 97 107 1:STN:280:DC%2BD2c7gs1Whug%3D%3D 10.1046/j.1365-2893.2003.00487.x (Pubitemid 38365759)
3. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein S, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B Virus Infection in the United States. MMWR Morb Mortal Wkly Rep 2005;54(RR16):1-23.
4. S Goldstein F Zhou S Hadler B Bell E Mast H Margolis 2005 A mathematical model to estimate global hepatitis B disease burden and vaccination impact Int J Epidemiol 34 1329 1339 10.1093/ije/dyi206 16249217 (Pubitemid 41819540)
5. CJ Chen LY Wang MW Yu 2000 Epidemiology of hepatitis B virus infection in the Asia-Pacific region J Gastroentol Hepatol 15 Suppl E3 E6 10.1046/j.1440-1746.2000.02124.x (Pubitemid 30435727)
6. World Health Organization (WHO). Hepatitis B. World Health Organization FACT SHEET 204 department of Communicable diseases Surveillance and response. 2008. Available at http://who.int/inf-fs/en/fact204.htm. Retrieved 12 Dec 2008.
7. C Franco-Paredes R Dismukes D Nicolls A Hidron K Workowski A Rodriguez-Morales, et al. 2007 Short report: persistent and untreated tropical infectious diseases among Sudanese refugees in the United States Am J Tropical Med Hygiene 77 4 635 663
8. World Health Organization. Vaccine-preventable diseases: monitoring systems, 2004 global summary. 2008. Available at http://www.who.int/vaccines- documents/GlobalSummary/GlobalSummary. Retrieved 15 Dec 2008.
9. Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of person with chronic hepatitis B virus infection. In surveillance summaries. 2008. Morbidity and Mortality Weekly Report (MMWR), 57 (No.RR-8).
10. EA Brooks LF Lacey SL Payne DW Miller 2001 Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States Am J Managed Care 7 7 677 682 1:STN:280: DC%2BD3MvhsFOgsQ%3D%3D
11. M Metcalf N Brown S Peterson 1999 Health care costs associated with chronic hepatitis B Am J Health Syst Pharm 56 3 232 236 1:STN:280: DyaK1M7ltlGkug%3D%3D 10030507
12. Margolis HS, Schatz GC, Kane MA. Development of recommendations for control of hepatitis B virus infection: the role of cost analysis. Vaccine. 1990;8 Suppl:S69-73; Discussion S93-94.
13. JB Wong RS Koff F Tine SG Pauker 1990 Cost-effectiveness of interferon alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B Ann Internal Med 122 9 664 675
14. WM Stauffer D Kamat PF Walker 2002 Screening of international immigrant, refugees, and adoptees Primary Care Clinical Office Practice 29 881 905
15. Ugwu C, Varkey P, Bagnieski S, Lesnick T. Sero-epidemiology of Hepatitis B among new refugees to Minnesota. J Immigrant Minority Health 2008;10:469-474.
16. Georgia Refugee Health Program. Refugees resettled in Georgia, 1995-2006. Georgia Refugee Health Program. 2007.
17. United States Census. Available at http://www.census.gov. Accessed 20 Oct 2009.
18. W Bond M Favero N Petersen C Gravelle J Ebert JE Maynard 1981 Survival of hepatitis B virus after drying and storage for one week Lancet 1 8219 550 551 1:STN:280:DyaL3M7ntFOmug%3D%3D 10.1016/S0140-6736(81)92877-4 6111645
19. Center for Disease Control and Prevention 1991 Screening for Hepatitis B infection among Refugees arriving in the United States 1979-1991 MMWR Morb Mortal Wkly Rep 40 45 784 786
20. Museru O, Franco CP. Epidemiology and clinical outcome of hepatitis B virus infection among refugees seen at a US. Travel Medicine Clinic: 2005-2008. J Travel Med Infect Dis 2009;7(3):171-174.
21. Fadman A. The spirit catches you and you fall down: a Hmong child, her American doctors and the collision of two cultures. New York: Farrar Straus, and Giroux; 1997.
22. G Fattovich F Bortolotti F Donato 2008 Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors Hepatology 48 335 352 10.1016/j.jhep.2007.11.011